 |
Program
The meeting’s main themes are: 1) Discuss novel roles for S1P, LPA, and other lysophospholipids in development, homeostasis, and disease; 2) Define common links in lysophospholipid biology that can foster collaboration and enable the translation of current research into clinical practice and public health benefit; 3) Identify disease biomarkers that reflect upon the fitness of lysophospholipid signaling and discuss novel therapeutic approaches and clinical trial results.Conference sessions will present the latest research and foster discussion on:
- Sphingosine kinases, S1P phosphatases and S1P lyase, S1PRs and S1P signaling
- Novel aspects of Autotaxin and LPA signaling
- Lysophospholipids in cancer biology and cardiovascular disease
- Lysophospholipids in immunology and inflammation
- Lysophospholipids in neurobiology
- Lysophospholipids in drug discovery, diagnostics, and clinical trials
- Novel bioactive lysophospholipids (e.g. lysophosphatidylserine, lysophosphatidylinositol, lysophosphatidylcholine) and emerging technologies
The conference features nine oral sessions with four poster sessions, “Meet the Expert” sessions, and career development workshops. A “Career Path and Development” session will include a section dedicated to women in science. We are delighted to have Timothy Hla, PhD (Harvard Medical School) and Wouter Moolenaar, PhD (The NKI-Netherlands) present the opening keynote lectures.
